Скачать или смотреть VicLink: Licensing Medical Drug Compounds from Victoria University to Biocryst

A New Zealand – US alliance generating commercial profits

The Ferrier Research Institute at Victoria University of Wellington has one of the most substantial track records in New Zealand of developing new medical drug compounds and, in close working relationship with partners in the pharmaceutical industry, transitioning these through the complex clinical development pathway to market.

Their most successful commercial deal (in conjunction with partners from Albert Einstein College of Medicine in New York), is a 16-year relationship with US NASDAQ-listed company BioCryst Pharmaceuticals, Inc. Under this licensing deal, four generations of novel compounds (covered by over 160 granted patents) have yielded six lead drug candidates with applications as diverse as Cancer, Gout, Psoriasis, Transplant Rejection and Malaria, as well as yielding potential treatments for Ebola, Zika and Marburg viruses.

Read More
https://kiwinet.org.nz/Awards/Awards2...